Caryl Ligan, Xin-Hua Ma, Shu-Li Zhao, Wei Zhao: The regulatory role and mechanism of mast cells in tumor microenvironment. Am J Cancer Res 2024;14(1):1-15. (Full text, PDF)
Kunzhi Zhang, Miao Zhou, Zui Zou, Chenglong Zhu, Ruoyu Jiang: Supraglottic airway devices: a powerful strategy in airway management. Am J Cancer Res 2024;14(1):16-32. (Full text, PDF)
Hao Bai, Lei Cheng, Wanting Liu, Wang-Yang Xu, Yingying Huo, Le Diao, Hao Ji, Liwen Xiong: Genetic alterations predict poor efficacy, outcomes and resistance to second-line osimertinib treatment in non-small cell lung cancer. Am J Cancer Res 2024;14(1):33-51. (Full text, PDF)
Min Liu, Qing Zhang: Polydatin ameliorates low-density lipoprotein cholesterol and lipid metabolism by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in triple-negative breast cancer with hyperlipidemia. Am J Cancer Res 2024;14(1):52-72. (Full text, PDF)
Zhen Liang, Tianrui Feng, Yi Zhou, Yongjiao Yang, Yujiao Sun, Zhien Zhou, Weigang Yan, Fenghong Cao: Nomograms for predicting clinically significant prostate cancer in men with PI-RADS-3 biparametric magnetic resonance imaging. Am J Cancer Res 2024;14(1):73-85. (Full text, PDF)
Lu Dai, Navneet Goyal, Jiawang Liu, Maryam Foroozesh, Zhiqiang Qin: Developing new ceramide analogs against non-small cell lung cancer (NSCLC). Am J Cancer Res 2024;14(1):86-96. (Full text, PDF)
Nayoung Kim, Min-Kyung Yeo, Pureum Sun, Dahye Lee, Duk Ki Kim, Song-I Lee, Chaeuk Chung, Da Hyun Kang, Jeong Eun Lee: Cathepsin C regulates tumor progression via the Yes-associated protein signaling pathway in non-small cell lung cancer. Am J Cancer Res 2024;14(1):97-113. (Full text, PDF)
Yaoqing Li, Guolin Zhang, Chuchu Xu, Liyijing Shen, Guangen Xu, Kewei Ji, Zhiqiang Lin: miR-99b/let-7e/miR-125a cluster suppresses pancreatic cancer through regulation of NR6A1. Am J Cancer Res 2024;14(1):114-129. (Full text, PDF)
You-Ci Zhou, Wen-Ji Lao, Yi-Lu Xu, Xi Huang, Chen Li, Zhen-Qiang Wang, Qi-Jun Wang, Yun-Wei Sun: Upregulation of circRNA_0023685 promotes gastric cancer progression via a circRNA-miRNA-mRNA interaction network. Am J Cancer Res 2024;14(1):130-144. (Full text, PDF)
Hong Li, Jie Zhao, Jingwei Yang, Jingyan Tang, Ting Zhang, Hui Jiang, Jingbo Shao: Bone marrow relapse in stage 4 neuroblastoma of children in Shanghai. Am J Cancer Res 2024;14(1):145-154. (Full text, PDF)
Yunfeng Zhang, Yongqi Ma, Jie Wang, Qiang Guan, Bo Yu: Construction and validation of a clinical prediction model for deep vein thrombosis in patients with digestive system tumors based on a machine learning. Am J Cancer Res 2024;14(1):155-168. (Full text, PDF)
Yuan-Chin Tsai, Shu-Pin Huang, Wei-Chung Cheng, Yu-Ching Fan, Ya-Ching Lin, Shin-Yu Tsai, Chao-Yuan Huang, Chia-Cheng Yu, Victor C Lin, Jiun-Hung Geng, Chia-Yang Li, Te-Ling Lu, Bo-Ying Bao: Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validation. Am J Cancer Res 2024;14(1):169-181. (Full text, PDF)
Meng-Han Tsai, Justin X Moore, Daramola N Cabral, Charles R Rogers, Jorge Cortes: Temporal trends in early-onset colorectal cancer incidence (2000-2020) by age group and five geographic regions in the state of Georgia. Am J Cancer Res 2024;14(1):182-191. (Full text, PDF)
Sabur Badmos, Elizabeth Noriega-Landa, Kiana L Holbrook, George E Quaye, Xiaogang Su, Qin Gao, Angelica A Chacon, Eric Adams, Thomas J Polascik, Adam S Feldman, Michael M Annabi, Wen-Yee Lee: Urinary volatile organic compounds in prostate cancer biopsy pathologic risk stratification using logistic regression and multivariate analysis models. Am J Cancer Res 2024;14(1):192-209. (Full text, PDF)
Jun Lou, Xiaoyan Chu, Xiaorong Yang, Muhammad Jamil, Hong Zhu: Deciphering DNA repair gene mutational landscape in uterine corpus endometrial carcinoma patients using next generation sequencing. Am J Cancer Res 2024;14(1):210-226. (Full text, PDF)
Erek D Nelson, Matthew GK Benesch, Rongrong Wu, Takashi Ishikawa, Kazuaki Takabe: High EIF4EBP1 expression reflects mTOR pathway activity and cancer cell proliferation and is a biomarker for poor breast cancer prognosis. Am J Cancer Res 2024;14(1):227-242. (Full text, PDF)
Xiaoyan Qian, Min Xiao, Yang Liu, Qing Li, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu, Pin Zhang: Clinicopathological and survival analysis of primary spindle cell carcinoma of the breast in Chinese patients. Am J Cancer Res 2024;14(1):243-252. (Full text, PDF)
Xin Yu, Chao Xu, Yiping Zou, Weishuai Liu, Yongjie Xie, Chao Wu: A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma. Am J Cancer Res 2024;14(1):253-273. (Full text, PDF, Table S1)
Rajib K Dutta, Yaa F Abu, Junyi Tao, Irina Chupikova, Janneth Oleas, Praveen K Singh, Nicolas A Vitari, Rehana Qureshi, Sundaram Ramakrishnan, Sabita Roy: Altered gut microbiome drives heightened pain sensitivity in a murine model of metastatic triple-negative breast cancer. Am J Cancer Res 2024;14(1):274-299. (Full text, PDF, Tables S1, S2)
Saud A Abdulsamad, Abdulghani A Naeem, Hao Zeng, Gang He, Xi Jin, Bandar A Alenezi, Jianzhong Ai, Jiacheng Zhang, Hongwen Ma, Philip S Rudland, Youqiang Ke: Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use. Am J Cancer Res 2024;14(1):300-323. (Full text, PDF)
Xuewu Tang, Kan Wang, Jinchao Yang, Yuting Wang, Zhiteng Yan: A novel immunogenic cell death-related gene risk signature can identify biomarkers of gliomas and predict the immunotherapeutic response. Am J Cancer Res 2024;14(1):324-343. (Full text, PDF)
Aydin Eresen, Yongsheng Pang, Zigeng Zhang, Qiaoming Hou, Zhilin Chen, Guangbo Yu, Yining Wang, Vahid Yaghmai, Zhuoli Zhang: Sorafenib plus memory like natural killer cell combination therapy in hepatocellular carcinoma. Am J Cancer Res 2024;14(1):344-354. (Full text, PDF)
Kohei Chida, Masanori Oshi, Nan An, Hirofumi Kanazawa, Arya M Roy, Gabriella K Mann, Li Yan, Itaru Endo, Kenichi Hakamada, Kazuaki Takabe: Gastric cancer with enhanced myogenesis is associated with less cell proliferation, enriched epithelial-to-mesenchymal transition and angiogenesis, and poor clinical outcomes. Am J Cancer Res 2024;14(1):355-367. (Full text, PDF)
Jacob J Adashek, Shumei Kato, Daisuke Nishizaki, Sarabjot Pabla, Mary K Nesline, Rebecca A Previs, Jeffrey M Conroy, Paul DePietro, Razelle Kurzrock: LAG-3 transcriptomic expression correlates linearly with other checkpoints, but not with clinical outcomes. Am J Cancer Res 2024;14(1):368-377. (Full text, PDF)
Nathan R Brand, Yi-Wei Yang, Vivianne Ding, Hannah Dutta, Csaba J Peto, Hassan Lemjabbar-Alaoui, David M Jablons: Novel dual action PARP and microtubule polymerization inhibitor AMXI-5001 powerfully inhibits growth of esophageal carcinoma both alone and in combination with radiotherapy. Am J Cancer Res 2024;14(1):378-389. (Full text, PDF)
Yufeng Shu, Xiaoyang Pang, Huan Li, Chao Deng: A multidimensional analysis of ZW10 interacting kinetochore protein in human tumors. Am J Cancer Res 2024;14(1):390-402. (Full text, PDF)
Yuanyuan Li, Han Lei, Rihan Hai, Guang Shu, Wenguang Yan, Gang Yin: HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3: Am J Cancer Res. 2022; 12(10): 4602-4621. Am J Cancer Res 2024;14(1):403-406. (Full text, PDF)
